1,10 PHENANTHROLINE MEDIATED HEMOLYSIS-EVIDENCE THAT 1,10 PHENANTHROLINE DOES NOT SUBSTITUTE SPECIFICALLY FOR C9BOYLE MDP; LANGONE JJ; BORSOS T et al.1979; MOL. IMMUNOL.; GBR; DA. 1979; VOL. 16; NO 5; PP. 307-312; BIBL. 20 REF.Article

Molecular weight of poly(C9): 12 to 18 C9 molecules form the transmembrane channel of complementTSCHOPP, J; ENGEL, A; PODACK, E. R et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 3, pp 1922-1928, issn 0021-9258Article

Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosisMORGAN, B. P; CAMPBELL, A. K; COMPSTON, D. A. S et al.Lancet (British edition). 1984, Vol 2, Num 8397, pp 251-255, issn 0140-6736Article

Immunoaffinity purification of human complement component C9 using monoclonal antibodiesMORGAN, B. P; DAW, R. A; SIDDLE, K et al.Journal of immunological methods. 1983, Vol 64, Num 3, pp 269-281, issn 0022-1759Article

DISTINCTION BETWEEN C8-MEDIATED AND C8/C9-MEDIATED HEMOLYSIS ON THE BASIS OF INDEPENDENT ⁸⁶RB AND HEMOGLOBIN RELEASEGEE AP; BOYLE MDP; BORSOS T et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 4; PP. 1905-1910; BIBL. 22 REF.Article

LYTIC ACTIVITY OF C5-9 COMPLEXES FOR ERYTHROCYTES FROM THE SPECIES OTHER THAN SHEEP: C9 RATHER THAN C8-DEPENDENT VARIATION IN LYTIC ACTIVITY.YAMAMOTO K.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 4; PP. 1482-1485; BIBL. 19 REF.Article

MATHEMATICAL ANALYSIS OF THE REACTION OF EAC 1-8 WITH C9: IDENTIFICATION OF PARAMETERS DEFINING CONDITIONS FOR MOLECULAR TITRATIONDELISI C; BOYLE MDP; BORSOS T et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 5; PP. 2334-2338; BIBL. 20 REF.Article

THE C5B-6 COMPLEX: REACTION WITH C7, C8, C9.PODACK ER; BIESECKER G; KOLB WP et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 2; PP. 484-490; BIBL. 32 REF.Article

INHERITED DEFICIENCY OF THE MINTH COMPONENT OF COMPLEMENT IN MANLINT TF; ZEITZ HJ; GEWURZ H et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 5; PP. 2252-2257; BIBL. 39 REF.Article

MOLECULAR ANALYSIS OF THE REACTION OF C9 WITH EAC1-8: REACTION OF C9 WITH EAC1-8KITAMURA H; INAI S.1974; J. IMMUNOL.; U.S.A.; DA. 1974; VOL. 113; NO 6; PP. 1992-2003; BIBL. 13REF.Article

The sequence and topology of human complement component C9STANLEY, K. K; KOCHER, H.-P; LUZIO, J. P et al.EMBO journal (Print). 1985, Vol 4, Num 2, pp 375-382, issn 0261-4189Article

Meningococcal meningitis in a woman with inherited deficiency of the minth component of complementFINE, D. P; GEWURZ, H; GRIFFISS, M et al.Clinical immunology and immunopathology (Print). 1983, Vol 28, Num 3, pp 413-417, issn 0090-1229Article

ANTI-C3D ANTIGLOBULIN REAGENTS. II.PREPARATION OF AN ANTIGLOBULIN SERUM MONOSPECIFIC FOR C3DMOORE JA; CHAPLIN H JR.1974; TRANSFUSION; U.S.A.; DA. 1974; VOL. 14; NO 5; PP. 416-424; BIBL. 6REF.Article

SOLUBLE C5B-9 COMPLEX OF GUINEA PIG COMPLEMENT: DEMONSTRATION OF ITS HETEROGENEITY AND THE MECHANISM OF ITS C9 HEMOLYTIC ACTIVITY AS TRANSFER OF REVERSIBLY BOUND C9 MOLECULES FROM THE COMPLEXKINOSHITA T; KYONGSU HONG; INOUE K et al.1981; MOL. IMMUNOL.; ISSN 0161-5890; GBR; DA. 1981; VOL. 18; NO 5; PP. 423-431; BIBL. 14 REF.Article

The size, shape and stability of complement component C9DISCIPIO, R. G.Molecular immunology. 1993, Vol 30, Num 12, pp 1097-1106, issn 0161-5890Article

AN AMPHIPHILIC STRUCTURE OF THE NINTH COMPONENT OF HUMAN COMPLEMENT: EVIDENCE FROM ANALYSIS OF FRAGMENTS PRODUCED BY ALPHA -THROMBINBIESECKER G; GERARD C; HUGLI TE et al.1982; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1982; VOL. 257; NO 5; PP. 2584-2590; BIBL. 34 REF.Article

DIFFERENCES IN CELL-BOUND C8 SITES ON CHICKEN ERYTHROCYTES MEASURED BY THEIR REACTIVITY WITH GUINEA PIG AND HUMAN C9BOYLE MDP; GEE AP; OKADA M et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 6; PP. 2818-2822; BIBL. 29 REF.Article

The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptorBIESECKER, G.The Journal of immunology (1950). 1990, Vol 145, Num 1, pp 209-214, issn 0022-1767Article

The ninth component of human complement (C9): functional activity of the b fragmentSHIVER, J. W; DANKERT, J. R; DONOVAN, J. J et al.The Journal of biological chemistry (Print). 1986, Vol 261, Num 21, pp 9629-9636, issn 0021-9258Article

The relationship between channel size and the number of C9 molecules in the C5b-9 complexRAMM, L. E; WHITLOW, M. B; MAYER, M. M et al.The Journal of immunology (1950). 1985, Vol 134, Num 4, pp 2594-2599, issn 0022-1767Article

COMPLEMENT LYSIS OF HUMAN ERYTHROCYTES. III: DIFFERING EFFECTIVENESS OF HUMAN AND GUINEA PIG C9 ON NORMAL AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CELLSROSENFELD SI; PACKMAN CH; JENKINS DE JR et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 5; PP. 2063-2068; BIBL. 23 REF.Article

EFFECT OF COMPLEMENT ON COLLAGEN-INDUCED PLATELET AGGREGATIONTIFFANY ML; PENNER JA.1980; J. LAB. CLIN. MED.; ISSN 0022-2143; USA; DA. 1980; VOL. 96; NO 5; PP. 796-802; BIBL. 26 REF.Article

C9 HEMOLYTIC ACTIVITY OF THE SOLUBLE C5B-9 COMPLEX OF GUINEA PIG COMPLEMENT, ANALOGOUS TO HUMAN SC5B-9KINOSHITA T; KYONGSU HONG; INOUE K et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 5; PP. 1989-1995; BIBL. 20 REF.Article

ON THE MECHANISM OF CELL MEMBRANE DAMAGE BY COMPLEMENT: EVIDENCE ON INSERTION OF POLYPEPTIDE CHAINS FROM C8 AND C9 INTO THE LIPID BILAYED OF ERYTHROCYTES.HAMMER CH; SHIN ML; ABRAMOVITZ AS et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 1; PP. 1-8; BIBL. 26 REF.Article

HUMAN COMPLEMENT C9 AND FACTOR B IN THE DIAGNOSIS OF INFECTIOUS IN INFANTSADINOLFI M.1982; ACTA PAEDIATRICA SCANDINAVICA; ISSN 0001-656X; SWE; DA. 1982; VOL. 71; NO 5; PP. 845-846; BIBL. 10 REF.Article